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Epidermal Langerhans cells are frequently anatomically 
associated with calcitonin gene-related peptide-con-
taining nerves. Furthennore, calcitonin gene-related pep-
tide inhibits Langerhans cells antigen-presenting function 
in several assays . Studies were perfonned to further 
explore the hypothesis that Langerhans cells and nerves 
have a functional relationship. To exan1ine whether 
Langerhans cells may produce factors that influence nerve 
cell differentiation, we utilized the Langerhans cell-like 
cell line XS52 as a surrogate for Langerhans cells and 
compared it with Langerhans cells enriched to 90%. 
Supernatants conditioned by lipopolysaccharide-stimu-
lated XS52 cells were able to induce the differentiation 
of the pheochromocytoma line PC12 into sympathetic 
neuron-like cells. This was also the case with enriched 
Langerhans cells stimulated by lipopolysaccharide. Pre-
treatnlent of conditioned supernatants with specific 
neutralizing anti-sera indicated that most of the differen-
tiation-inducing activity was due to interleukin-6 and a 
sn1all amount was due to nerve growth factor and basic 
fibroblast growth factor. By reverse transcriptase poly-
merase chain reaction, three clones of the XS52 cell 
I nA amma to ry skin disorders such as psoriasis and atopi c dermatitis are an ecdow lly reported to wo rsen w ith anx iety (LamnLintausta el a/, .1 991; A\' Abadi e c/ a/, '1994a). Additional ly, so me repo rts have suggested th at express ion of pso riasis depends on normal irmerva tion of the skin (Dewin g;, 197 1; Eedy el a/, '199 '1; 
R aychaudhuri and Farber, 1993) . T herefore, a fun ctio nal relationship 
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line, XS52-4D, XS52-11D, and XS52-8B, were found to 
express tnRNA for interleuk.in-6 and expression was 
markedly augmented by lipopolysaccharide. mRNA for 
nerve growth factor and basic fibroblast growth factor 
was detected in XS52-4D and XS52-11D, but not in 
XS52- 8B. The expression of these neurotrophic factors 
by enriched Langerhans cells was quite similar to that of 
XS52-4D. In order to examine whether Langerhans cells 
1nay express receptors for nerve-derived peptides, t·everse 
transcriptase polymerase chain reaction was en1ployed to 
look for pituitary adenylate cyclase activating polypeptide 
type I, type II, and type III, and gastrin-releasing peptide 
receptors. All clones exan1ined, as well as enriched 
Langerhans cells, expressed pituitary adenylate cyclase 
activating polypeptide type II and type III, and gastrin-
releasing peptide receptors. These results suggest bi-
directional signalling between Langerhans cells and 
nerves; nerve cells tnay regulate Langerhans cell function 
by elaboration of certain neuropeptides whereas 
Langerhans cells 1nay promote the differentation of nerves 
by elaboration of interleukin-6 and, possibly, other fac-
tors. Key words: deudritic cells/IL-6/mouse.] l 11 JJest Derma to/ 
109:586-591, 1997 
between antigen presentation in the ski n and th e nervous system may 
no t be un ex pected. Langerh ans cells are epiderma l dendritic antigen-
presen ting cells that have been shown to be capable of pres nting 
several antigens for CD4- dependent immun e respo nses (Stin g! et a/, 
1977; Romani cr a/, 1989). T he function of th ese ce ll s is regulated by 
several cy to kines including granulocyte-ma croph age colony stimulating 
f:1 cto r (G M -CS F) and interl eukin- 10 (I L- 1 0) , am o ngst othe rs (Enk 
cJ a/, 1993; Larse n et a!, 1994). Interes tin gly, these ce lls are fi· equently 
found to be closely associated anatomi ca ll y w ith epidermal ne rves 
contai nin g th e neuro peptide calcitonin gene-re lated peptide (CGRP), 
whi ch has been found to inhibit the ab ility o f Langerhans cells to 
present antigen in several systems (H osoi c/ a/, 1993). T his effect of 
CGRP has been shown to be receptor mediated (Asahina ct a/, 1995) 
and invo lves augmentation o f I L-10 produ ctio n, inhibitio n of IL- ·1 p 
and I L- 12 produ ction , and inhibitio n of the upregulati on of th e co-
stimulatory mol ecul e 137-2 (To rii et of, 1997) . 
A number of neuropeptides are present in cutaneo us nerves in 
add ition to CG R..P, including substan ce P, pituitary adenylate cyclase 
ac tivating polypeptide (PA C AP) , in some repo rts vasoactive intes tinal 
polypeptide (VIP), and poss ibly gastrin - re leasin g peptide (G R.P) 
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Qo hansson , \ 986 ; Dalsgaard ct a/, 1989; Hardebo cl a/ , 1992; M o lle r 
ct a!, '1993; AJ'Abadie ct a/, l. 994b). In addition , afte r encountering 
an tigen and tnfficking to regio nal lymph nodes, Langerhans cell s may 
en counter o ther n euro hormones as lymph nodes are inn erva ted (Giro n 
ct a/, 1980; Wa lker and Codd, 1985). Additiona.l support for this 
con cept com es ti·om the recent report that Langerhans ceUs express 
GRP recepto rs as assessed b y staining w ith anti-GRP receptor anti-
bodies (S tan ie k el a/, 1995) . T h erefore, we wish ed to investi ga te 
wheth er Langerbans cells express receptors for certain n euro peprid es. 
Additionally, because Langerhans ce lls are so freque ntly associated w ith 
epidermal nerves, we al so soug ht to in ves tigate w hethe r they may 
secre te fac to rs capab le of regula ring neuron physio logy. 
A m ajor impedim ent to performing these studies res ides in the E1 ct 
that Langerh ans cel.l s make up o nly 2% of the total epidermal ce ll 
population. Thus, in order to obtain purified populations o f Lan gerhans 
cel.ls, separation techniques must be employed to o btain hi ghly purifi ed 
populations of cells. Su ch techniqu es, however, result in th e isobtion 
of re latively tew cells, m aki ng it difli cult to examine protein pro du ction 
o r perform northern ana lysis. Furthe rmo re, even th ese highly purified 
preparations contain "" 'I 0% co nwnin:Jting keratinocytes, making ana-
lyses by the polym erase chain rea ctio n (PC R.) techniqu es diffi cult to 
interpre t. Fortunately, th e recent development of long-lived lin es of 
dendriti c cells deri ved fi·om neonatal epidermis allowed us to use a 
comp.le te ly homogeneous populati o n of Langerhans cell - like cells as 
surroga tes for Langerh:1ns ce lls (Xu cf a/, '1995a). We exam.ined three 
clon es of the Langerh ans ceLl - li ke ceLl lin e XS52 (det;ved li01n n eonata l 
BALB/c ep idermis) for expression of several ne uro trophi c fa c tors and 
ne uropept ide receptors. Althou gh it may not be poss ible to be 
co mple te ly certain that XS52 cells dup lica te th.e normal physiology of 
Lan gerhans cell s, the ir ph en o ty p e is similar or identical to Lan gerhans 
ceiJ s, including their ab ility to present antigen (Xu ct a/, .199Sa,b,c; 
Takashima ef a/, 1995) . 
Th e expressio n of th ese neurotrophic f.1cto rs and neuropeptide 
receptors by Langerhans ce ll s enrich ed to 90'){, was also examined and 
Colllpared with th~t of XS52 cell s. 
MATER.IALS AND METHO DS 
Reagents Lipopolysaccharide (LPS), nerve grow th f:rcto r (NGF), rabbit anti-
mouse IL-6 anribody, rabbit anr:i-mouse NGF antibody, and rabbit lgG were 
purchased fi·om Sigma (S t. Louis, MO) . Murine recombinant IL-6 was fi·om 
.E ndogen (Woburn, MA). ll..:rr rail collagen type I was fi·om 13eckton Dickinson 
(Bedford. MA). R abbit ami- recombinant b,tsic fibroblast growth f.1 ctor (bFGF) 
was obtai ned fi·om 13ionredical Technologies (S toughton, MA). 
Mice Six- to 12-wk-o\d l·e mal BALI3/ c rn tce were purchased fi·om th e 
Jackson Laborato ry (l:lar Harbor, ME). 
Cell lines 
XS52 rells Several subclones of the XS52 cel l line were the kind gifi·s of A. 
Tabshinra (University of Texas, So uthwestern Medical Center, Dallas, T X). 
XS52 cells were pt·epared fi·omneonata i .13ALB/ c epidermis and several subclones 
prep ~rred by limiting dilu tion cloning (Xu eta/ , 1995a,c) . As prev iously described, 
tl1 ese ce lls are dend ri tic, capable of antigc·n presentation , and have man y 
phenotypic characteristics of Langerhans cel ls (X u ct ttl, ·1995,1,b,c; Takashima 
et nl, 1995). T hese cells we re propagated in ll..l'M I medium contain ing I 0% 
fe tal ca lf se runr, 10 U reconrbinant murine GM-CSF pe~ ntl (13iosource Int., 
Camari llo, CA) , and IO'Y., NS cell supernatant (Xu eta/ , 1995a) . Three clones 
of this li ne, termed XS52-4D. XS52- Il D , and XS52-8B, with the same 
characteristi cs as the parent line (Xu cl a/, 1995c), were utili zed in these 
experi1n ents. 
I'C I 2 ndls T he pheochronrocytonra line PC l 2, which difle rentiates in to 
nerve-like ceLls under the influence of certai n neurotrophic f.1c tors including 
N G F, lL-6, and acidic and basic fibr blast growth f.1cto1· (Nabfuku er a/, 1992), 
was obtained fi·om. the American Type C ulture Coll ection (ATCC, R ockville, 
MD). PC 12 cells were propagated iu 11itn> in !<.I'M I medium contain ing 1. 0'){, 
horse serurn and 5'){, fe tal calf serum (L'C 12 medium). 
Preparation of epidermal ce lls BA LB / c epidermal cdls were obtained by 
using a modification of a stand:n·d protocol (G rabbe cl a/, 199 1 ). Truncal skins 
were shaved , clwmka ll y depilated , removed fi·ont euthani zed rni cc and dep.le ted 
of subcutaneo us f.Lt and panniculus carn osus by blunt dissectio n. T he skins we 1:e 
floated dermis-side down on 0.5 U dispose per ml (Boehringe r, Indianapolis, 
IN) and 0.38% trypsin (Sigma) in Ca2+ / Mfil+ -free phosphate-buffered saline 
for 40 min at 37°C. Epidermal sheets were collected and dissociated in Hanks' 
ba lanced salt so \utjon supplemented with 2% hea t-inacti va ted feta l ca lf serum 
by continuous gentle agitation for ·15 n'lin. Epidermal ceLls were fi ltered through 
nylon gauge and washed in Hanks' balanced sa lr so.lu tion with 2% fe ta.l calf serum. 
Langerhans cell en richment BA Ll3/ c epiderma.l cells were suspended at 
=·I 07 per rnl and monoclona.l ami-mouse T hy ·1.2 antibody (Sigma) was added 
to a fi nal di lution of 1 :2000. After 30 min incubation on ice, the cells were 
was hed t\ov ice to rern ove excess antibody. Th e ceJ l.~i were then inc ubated w ith 
complement at a di lution of I :40 for 30 min at 37°C. After washing 
with Ca2+ / Mg2+ - fi·ee phosphate-buffered saline, dead cells were removed by 
treatmem with 0.05% tt)'psin and DNase (Sigma) at 80 ~Lg per ml for 3 min at 
room temperature. The cell s were then. incubated with mouse anti -1-A d 
(Pharmingen, San D iego, C A) for 30 min on ice fo Uow"d by incubation with 
goat anri-mousc lgG conjugated to magnetic microspheres (Dynabea cls M--+50, 
Dynal. Lake Success, NY) for 30 min on ice. The cells were then separated 
into t\VO fi·;lCti ons by washing under a n1agn eti c field , and those ,.vith attached 
magm:ti c beads were designated as enriched La ngerhans cells, whereas those 
without were designated as keratinocytes. Langerltans ce lls can be enriched to 
90')(, by this method assessed by flow cytometry (data n.ot shown). 
Assay for PC12 cell differentiation O ne million XS52-4D , XS52- l'ID, 
XS52-8B, or enriched Langerhans cells in 1 nu PC'I2 medium were cultured 
in '12-we\1 plates at 37°C f; r 24 h in the presence or absence of 1 ~Lg LPS per 
mi. Supernatants were obtai ned and then passed through 0.45-]..tm filte rs. Five 
hundred micro liters of conditioned supernatants were added to 500 ]..tl of PC'I2 
medium containing 3 X I 04 PC 12 cells per well in '12-we\1 plates coated with 
type I collagen. Control cultures had nonconditioned medium added. Cells 
we re observed at 12 h intervals with an in verted phase contrast microscope for 
evidence of neurona l diiTerenriation of PC 12 e lls. Each condition was cacTied 
our in triplicate. 
Reverse transcriptasc-PCR (RT-PCR) XS52-4D, XS52- 11 D, XS52-813, 
or enriched Langerhans cells "vere cultmed without GM-CSF or NS supernatanr 
for -+8 h and then cultured fo r () h in medium with or without I p.g LPS per 
mi. Poly A + RNA was extracted fi·om tlr ose cells (Dynabeads mRNA 
D l RECT kit, Dynal) and R T-PC I<.. was performed for neurotrophic factors 
and neuropeptide receptors using a ll.. T-PCR kit (GencA mp RNA PC R kit, 
Perkin Elmer Cetus, N orwalk , CT). l3rieAy, 0.1 pg ofi<..NA was incub,lted in 
a reac tion mixture containing 5 mM rvlgC\2, 50 .mM KCI, JO mM Tris-HCI, 
I mM ciNTPs, 2.5 ~LM random hexa mers, I U RN ase inhibitor per pJ , and 
2.5 U M- M LV reverse transcri ptase per ~tl in 20 pi for I 0 min at room 
te mpe rature for rh e exte nsion of the h exaJn e t~i c prim ers ~ for J 5 min at 42°C 
for an neaLin g, and then for 5 min at 99°C to denature the enzyme. Twelve 
nucmliters of the reverse transcribed reaction was transfeJTed to a PCR reaction 
mixture for neurotrophic tacro rs and neuropeptide receptors and 6 pJ of the 
reverse transcribed reactio n \Vas tran sfe rred fi·on1 th e sa me tube to a PCR. 
reac tion mi xture fo r g\ycera \de hyde-3-phosphate dehydrogenase (GA PDH) as 
an interna l control. T he reaction mixture consisted of 50 mM KCI, '10 mM 
T ris-HC I, 2 m/Vl MgCI2, and 0.5 p.!Vl primers :mel I U AmpliT.1q DNA 
Polymerase in a to tal volu me of 40 ]..tl. 
Pri111crs were designed usin g n1 ouse sequ ences in Ge nbank (5 1 ACCACGG-
CCTTCCCTACTTC3' and 5' ACTCTGGCTTTGTCTTTCTT3' for IL-6, 
5' ACTCTGATCACTGCGTTTTT3' and 5' CCT CTTCTTGTAGCCTT-
CCT3' for NGF, 5'CAGGAGCGAGACCCCACTAA3' and S'GGCAT-
CGAAGGTGGAA GAGT3' for GAPDB , 5' AGCAGCCAAACGGAGA-
ATCA3' and S'CCACCAGAAGCCAGTAGAAG3' for PACA P type Ill 
receptor, and 5'CAGAACCAACATCAACAAAC3' and 5' AACAACATA-
GAGACAAT CCA3' for GRP receptor). Primer sequences fo r bFGF were as 
prev ious ly described ([.canard er nl. 1993) (5'AAGCGGCTCTACTGCAA-
GAACG3' and 5'TTCTGTCCAGGTCCCGTTTTGG3'). R at sequences 
were used for PAC AP type I and ll receptors (5'TGTGGGTTTGATGATTAT-
GAG3' and 5' GAT GATGATGATGCCGAT GAA3' for type I receptor _ and 
5' ACAGCGGGG AGATAGACCAC3' and 5' AAACAGGGGGATGAGCA-
GAA3' for ry pe II receptor). t\fter denaturation fo r 5 min at 95°C. 30 cycles 
for IL-6, 35 cycles fo r NGF and bFGF, 25 cycles fo r GAPDl-.1 or -+0 cycles fo r 
neuropetide receptors of denaturation for 30 s at 95°C, annea.ling fo r 30 s at 
55°C, and extension fo r 30 sat 72°C were repea ted with a thermal cycler (type 
450, Perkin Elmer Cetus) followed by completion for 5 min at 72°C. The 
Pe rt produ ct was electrophoresed in 1% agarose gel , sta ined with ethidiuin1 
bromide, and visua lized with ultraviolet radiation. 
E nzyme-linked immunosorbent assay (ELISA) for IL-6 and 
NGF XS52-4D , XS52-'I 'I D. XS52-8Il , or enriched Langcrlrans cells were 
cultured without GM-CS F or NS supermtant for 48 h. T hey were then 
cultured in PC 12 medium at a concentration of ·10° cells per rn.l for 24 h at 
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Figure 1. Supernatant conditioned by stimulated XS52 cells or 
stimulated enriched Langcrhans cells induces PC12 cells to differentiate 
into sympathetic neuron-like cells . (A) PC12 cells cultured in medium 
alone. Most of them are in round to ova l shape with few short processes. (B) 
PC12 cells exposed to supernatants condi tioned by XS52-4D cells stimulated 
with 1 jlg LPS per mi. Note wciJ differe ntioted state of cells with many long-
neLnite-li ke processes. Scale bnrs, 25 ~Lm . 
37°C with or without I ~Lg LPS per mi . Nega ti vely se lec ted kcratinocytes were 
cul tu red in the same man ner. ll-6 and NG F production at the protein level in 
the cul ture supe rn ata nts we re assayed. 
Measurement of ll -6 in XS52 or enriched Lange rhans ce iJs supernatants was 
performed by an ELI SA ki t (Endogen). ELI SA fo r NG F was ca rded out with 
two monoclonal antibodies against the ~-su bu n it of mouse NGF fo !Jowing the 
manuGcturer's instructions (Boehringer). BrieRy, a 96-wdl plate was coated 
with a nti -~NGF fo r 2 h. After removal of the antibody, the plate was incubated 
tor 30 min with bovine serum albumin solution for blocking. After washing 
out the blocking solution, supernatants were added and incubated overn ight at 
4°C. After was hi ng, ~-ga lactos idase-conjug;t ted -ant i - ~NGF was added and 4 h 
later, CPRG was added as a substrate and the developing color was ph otometric-
all y determined. Each assay was perfo rmed in tripli cate. 
Neutralization with anti-sera to IL-6, NGF, and bFGF Q uantitative 
bioassay of neurotrophic fac tors using PCJ 2 cells (R.ukenstein and Greene, 
1983; Te ct a/, 1994) was perfo rmed. PC 12 cells were prcincubated with 50 ng 
NG F per ml fo r 10 din co ll agen-coated plates. During this procedure, P 12 
cdls we re extend ing nt: uri te- tikc processes. After pre incu bation , cells were 
de tached by vigorous pipetting and washed extensively three times to remove 
NGF and to cause retrac tion of th e processes. Thirty thousand PC J2 ce lls were 
then resuspended in 500 ~I of PCl 2 medium and n.:plated in collagen-coated 
12-well pla tes . 
Cul ture supernatants conditioned by XS52-4D cells stimula ted with I jlg 
LPS per mJ were obta ined as descri bed above and preincubated with "10 ~g 
neutra lizing anti-sera per ml to IL-6, NGF, bi'GF, combinations of these anti -
sera, no anti-se ra, or controf IgG . Pre- incubation was perfo rmed for 30 min 
on ice foJl owcd by the addi tion of 500 jll of supernata nts to 500 jll of 3 X I 04 
I'C12 cells per we ll. NGF was added to some wells at a fin al concentration of 
SO ng per ml as a positive contro l. T he e!Tects of murine recombin,mt !L-6 
and NGF at different concentrations in this assay were also exa mined. Each 
was ca rried out in quad ru plicate. 
Twenty-four hours la ter, PC12 cdls were regenerating neurite-lik <O processes 
and the percentage of process-bearing cells was quan ti tatively related to the 
amount of neuro trophic f.1cto rs. O ne hu ndred cells per well were assessed 
mi croscopica ll y fo r the presence of d10ndrites in a coded manner. 
Stratistics T he significance of differences amongs t groups in ELI SA and 
neutrali zation assay experiments was assessed by Student's two-tail ed t test lor 
unlJaired samples. 
R ESULTS 
Supernatants from stimulated XS52 cells or stimulated enriched 
Langerhans cells induce PC12 cell differentiation Th e abili ty of 
supe rnatants co nditio ned by XS52-4 D , XSS2-1 'I D , o r XS52-8B 
to induce differentiation o f PC12 cells was assessed. Supernatants 
conditio ned by these unstimulated cells had little or no ac ti vity; 
however, w hen cells were stimulated with l !J.g LPS per nl.l , supe rnatan ts 
·onditi oned by each of th e three clo nes indu ced PC 12 cells to 
diffe rentiate into sym pa theti c neuron- like cells (Fig 1). T his activ ity 
could also be induced by supernatant fro m enri ched Langerhans ce lls 
only w hen stimulated by l fl .g LPS per mi. O ne mi crogram LPS pe r 
tnl alone had no effect in this assay (data not shown) . 
Expression of mRNA for IL-6, NGF, and bFGF by XS52 cell 
clones and enriched Langerhans cells Expressio n of m.R.NA fo r 
T H E JOUR NAL OF INVESTI GATIVE DEI"lMATO LOGY 
IL-6 
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NGF 
bFGF 
GAPDH 
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Figure 2. mRNAs for neurotrophic factors arc expressed by XS52 cell 
clones and enriched Langerhans cells. Poly A+ RNA was ex tracted fi·om 
XS52-4D, XS52- 111 , XS52-8D, and enriched Langerhans cells with or 
without st imulation of 1 jlg LPS per ml fo r 6 h. eDNA was synthesized and 
PCI\. was performed fo r IL-6, NGF, :tnd bFGF. The housekeeping gene 
GAP DH was used as an internal control. ·Ja, XS52-4D; l b. stimulated XS52-
4D; 2a, XS52-1 J D; 2b, stimulated XS52-1 'I D; ]a, XS52-8B; Jb, stimulated 
XS52-8B; 4a, emichecl Langerhans cells; 4b, stimulated emiched Langerhans 
ce lls. 
IL-6, N G F, ;md bFG F by XS52 ce ll clo nes and enri ched Langerhans 
cells was analysed by RT- PC R (Fig 2). G APD H was used as an 
internal contro l. XS52-4 D , XS52-1 1D, and XS52-813 ce lls expressed 
mRNA fo r IL-6 and IL-6 mRN A expression was markedly augm ented 
by LPS in all three clones. nl.l<..NA fo r N G F w as detec ted in XS52-
4D cells and Gintl y in XS52-1ID cells but was not fo und in X S52-
8B cells. NG F mR N A expressio n did no t appea r to be augm ented by 
LPS in XS52-4D o r XS52-1 1D cell s. 
mRNA fo r bFG F was fo und in XS52-4D and XS52-J 1 D cells but 
no t in XS52- 8B cells. N o increase in bFG F n1.R.NA was seen after 
LPS stimula tion . The express ion of iL- 6, N G F, and bFGF by enriched 
Langerhans cells was qui te similar to that ofXS52-4D , as w as regula tio n 
of expression by LPS. Acidi c FG F was no t found in any o fth ese cl o nes 
o r enri ched Langerhans ce ll s (data n o t shown). 
Production of IL-6 and NGF proteins by XS52 cell clones and 
enriched Langerhans cells XS52-4D, XS52-llD , and XS52-8B 
as well as enriched La ngerh ans ce lls produced lL-6 at the pro tein level 
and its produ cti on was hi ghl y augmented by 1 ~Lg LPS per ml 
stimulati on. Th e data in Fig 3 show IL-6 production by XS52-4D 
and enri ched Langerhans cells w ith and w itho ut LPS stimubtio n . lL-6 
also co uld be detec ted in supernatants co nditi oned by negati ve ly 
selected ke ratin ocytes; however, th e amo unt produced was much 
sm aller even after LPS stimulatio n . 
N GF produ ction was detected bo th in XS52-4D cell superr1 atants 
and in enriched Lan gerhans cells supernatants by ELISA (Fig 4), but 
no t in XS52-11D o r XS52-8B cells (data no t shown) . LPS did no t 
augment NG F production. N egati vely se lected keratinocytes produ ced 
a larger amo unt of N G F. 
Inhibition of PC12 neurite formation induced by XS52 cell-
conditioned supernatants by anti-sera to IL-6, NGF, and 
bFGF Q uantitati ve bioassay of PC 12 cell differentiati on was per-
fo rmed to in vestiga te w hi ch Gctors were respo nsible for PC 12 ce ll 
differentiati on. C ulture supernatants conditioned by LPS-stimulated 
X SS2-4 D cells were p reincubated w ith neutrali zing anti-sera to IL-6, 
N GF, bFG F, o r combinations of th ese anti-sera. Printed PC 12 ceUs 
were do ubly diluted w ith these supernatants and th e p ro po rtion of 
process-bea rin g ce lls after 24 h in cubation in each gro up are shown 
in Fig Sa. 
Fifty nanograms N G F pe r ml indu ced process extension of PC 12 
cells in mo re than 80% of the to tal cell populatio n and LPS-stimulated 
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Figure 3. IL-6 is detected and highly augmen ted by LPS in XS52-
4D and enriched Langerhans cells supernatants. XS52-+D, enriched 
Langerhans ce lls, or negatively sdec tecl kerari t~ocyres were cultured in l'C 12 
medium at a concentration of I 01' cells per ml for 2-l h at 37°C witb or without 
1 ~l g LPS per mi. The culture supernatanats were assayed for (L-6 by ELISA. 
Each assay was performed in tri pli ca te. Error bars arc ± SD. XS52-+D tlf' IC<tiS 
stimuhted XS52-4D, p < 0.001; enriched Langerhans cel ls lleWIS stimuhted 
enriched Lange rhans ce lls, p < 0.00 1; stimulated XS52-4 D l'i' I'SIIS stimulated 
keJ~ltinocytes, p < o.oo·r; stimubted enriched Langerhans cdls \JCrSIIS stimubted 
ker,uinocytes, p < 0.00'1. 
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Figure 4. NGF is detected in XS52-4D and enriched Langerhans cells 
supernatants. XS52-4D, enriched Langcrhans cdls, or negatively selected 
keratinocytes were culwred in PC 'I2 medium at .1 concentration of 101' cells 
per ml for 24 h at 37°C with or without I pg LI'S per rnl. The culture 
supernatanats were assayed for NGF by ELI SA. Each assay was performed in 
triplicate. Error bars are ± 51 XS52-.JD f!enw· scimulatl'd XS52-.JD, not 
signiftcant (NS); 1011riched Langerhans cells '" ' I'SIIs stintubtt!d emiched Langerhans 
ce lls, NS; stimulated XS52-4D vcrs 11s stimulated ke ratinocytes, p < 0.00 I; 
sti mulated enriched Langerhans cells vers11s stimulated keratinocytes, p < 0.00 1. 
XS52-4D ce ll supernatants exhibited this e!Jecr in =70'3{, of ce lls. Pre-
incubation w ith neutrali zing anti-se ra to IL-6 signifi cantly inhibited 
this effect w hereas anti-sera to bFGF and NGF had lesse r inhibit01-y 
effects. Combination of these ami-sera had a more potent inhi bitory 
effect than each alon e . . Addition of contro ll gG had no effect in this assay. 
NGF-induced PC12 cell dilkrentiation was not inhibited by ami-
se ra to IL-6 o r anti-sera to bFGF (data not shown). 
The concentration-response relationsh.ip of IL-6 and NG F to 
indu cti o n of neurites in PC 12 celb was exam ined. A concentration-
dependent indu ction of neurite formation was shown by 0.2-5 ng 
IL-6 per n1.l and 4-100 pg NGF per ml (Fig Sb). Th e am o unts of 
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Figure 5. (a) Neutralizing assay of neurotrophic factors u sing PC12 
cells. C ulture supern:>tant conditioned by LPS-stimulatcd XS52-4D cells was 
preincubated with 10 pg neutrali zing anti-sera per ml to IL-6, NGF, bFGF, 
con1bin:1rion.s oF these ,1 n ti-ser::1, no :l nti -ser::~, o r control lg ' · Primed PC 12 
cells were exposed to the preincubated su pern.,tant for 24 h. Some cells were 
exposed to 51) ng NGF per ml as a positive comrol. Each was performed in 
qu:tdruplica te. O ne hundred ce lls per wdl were assessed lllicroscopica ll y fo r rhe 
presence of dendrites in a coded manner. Error bars arc ± SD. Supernatam 
versus supernatant + anri- IL-6, p < 0.00 I: supernatant JICI'Sus supernatant + 
:mti-bFGF, p = 0.033; supernatant JJersus supernatant + anti-NGF, p = 0.017; 
supemat:lllt J'I'WIS supcm ;J t:mt + ami-IL-6 + :lllci-bFGF, p < ().001; supernatant 
1JC1:ws supema ra nt + anti- IL-6 + anti-NGF, p < 0.001; supernatant IIC' I'SII.< 
supernata nt + anti - IL-6 + anti-bFGF + :lllti -NG F, p < 0.001 . (I!) 
Concentration-response effects of IL-6 and NGF on PC12 cell 
d ifferentiation. Murine rccombin:1 nt JL-6 or NGF :lt different concentr:Jti o ns 
were added in the primed PC I2 cell cul ture and incubated for 24 h. One 
hundred ce lls per we ll were assessed microscopically for the presence of dendrites 
in a coded 111anner. Error b;~rs are ± SD. IL-6: nt:gative versus 0.2 ng per mi. 
,N S; n~g:ative PCI'S II S I ng per n1.l , p = 0.002; negative IIC/"SIIS 5 ng per mJ , p = 
0.00 I. NGF: nega tive tJcrs us 4 pg per rnl, NS; negnive tiers us 20 pg per ml, 
p = O.O.JS: negative /Jm'IIS 100 pg per ml, p = 0.003. 
lL-6 and NGF produced by XS52-4D cells were in the middle of 
these ranges under these conditions of culwre. 
Neuropeptide receptors on XS52 cell clones and enriched 
Langerhans cells Neuropeptide receptors o n XS52 cell clones and 
enriched Langerhans cells were investiga Led b y reverse transcriptase-
PCR.. XS52-4D, XS52- llD, and XS52-8B ce ll$ were fo und to express 
mRNA for PACAP type II and type Il l receptors, w he reas type 1 
receptor appeared to be absen t fi·om all of th ese clon es. All clones 
conwined m.n . .NA for the GR.P receptor (Fig 6a) . A simibr expression 
pattern of th ese ne uropeptide receptors was sh own by enri ched 
Langcrhans cells (Fig 6b ). 
The presence of neuromedin K-·1 (NK-1 ), NK-2, NK-3 receptors 
was also investiga ted , but no ne of these receptors were de tec ted by 
reverse transcriptase- PC R (data not shown). 
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Figure 6. (a) mRNAs for neuropeptide receptors are expressed by XS52 
cell clones. Poly A+ l<.NA was extrocted from XS52--4D ( '1), XS52- 11 D (2), 
and XS52-8B cells (3) and eDNA was synthes ized. PC !<. was performed for 
PACAP type 1, type ll , and type Ill , and G1<.P receptors. Expected sizes were 
591 bp for PACAP type 1, 452 bp for PA CAP type II , 541 bp for PA CAP type 
111 , and 736 bp for GRP receptors. (b) mRNAs for neuropeptide receptors 
are expressed by enriched Langerhans cells. Poly A+ l'tN.A was extracted 
fro m enriched Langerhans cells and eDNA was synthesized. PCR was performed 
for PACAP type l, type II , ond type Ill , and GR.P receptors. 
DISCUSS ION 
The ability of Langerhans ceJJs to present an tigen has recently been 
show n to be regu lated by th e neuw peptide CGRP (f-losoi ct a/, 1993; 
Asahina et a/, 1995). Furthermore, Langerhans cells have been shown 
to be fi:equently in anato1i1ic association with CGRP-containin g nerves 
(Hosoi eta/, 1993). These relati o nships suggest the possibility that the 
nervous system regulates antigen presentation in the epidermis by 
release or nonrelease of regulatory substan ces by epidermal nerves. The 
experiments discussed above provide further evidence for a functionaJ 
relationship berween nerves and Langerhans cel.ls. The finding that 
Langerhans ceJJs possess additiona l neuropeptide of receptors in cluding 
PACAP type II , PAC AP type Ill , and GRP receptors suggests tl1at 
other neuropeptides may influ ence Langerhans ceJJs behavior. ln this 
regard, it has been demonstrated that PA CAP is present in epidermal 
nerves (MaUer et al, 1993) and there have been some reports that V LP 
and GRP may also be present in ep idermal nerves, at least in some 
species (Jo hamson, 1986; D alsgaard ct a/, 1989; L-:!ardebo et a/, 1992; 
AJ 'Abadie et a/, 1994b). The possible effects of th ese neuropeptides, 
their interactions with each other, and their interactions with inm1Uno r-
eguhtory cytokines is an area of continuing investigation. 
The data demonstra ting that XS52 ce lls as we Ll as a populatio n of 
cells enri ched to 90% Langerhans cells content ca n produ ce neuro-
trophic facto rs, suggest that Langerhans cells may influence nerve 
behavior, thus indi cating that bi-directional signalling between nerves 
and Langerhans ce lls could exist. We found that the Langerhans' ce ll-
like cell lin es and enriched Langerhans cells produ ce a large :11nount 
of IL-6, son1.e NGF, and some bFGF. Of interest , keratinocytes are 
known to produ ce NGF (Pin celli ct a/, 1994); however, to the best of 
our knowledge, N GF productio n by Langerhans ceUs has no t been 
previously reported. NGF, JL-6, and bFGF all have potent influ ences 
on n erve cells. bFG F is an impo rtant factor for neurite extension in 
Xenopus retinal ganglion cells (McFarlane el a/, 1995) and N GF has 
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trophi c influences on neurite development in th e adult as weJJ as th e 
embryo (Yasuda cl al, 1990; H.ori e and Akah.ori, 1994). C ultured 
mo use embryoni c dorsal root ganglia cells exhibit dramatic neurite 
extension by simultaneous addition of IL-6 and soluble lL-6 recepto r, 
and IL-6 production is upregulated after transection injury to nerves 
(Hirota et nl, 1996). Furthermore, IL-6 has been repo rted to play a 
rol e in the o utgrowth of neurites from murine supetior cervical ga nglia 
cells cultured w ith lymphoid tissue (Kannan c/ a/, 1996) . Also of 
interest, binding of NGF to receprors on peripheral nerves leads to 
augm ented expression of CGRP i.n dorsal root ga nglia cells (Watson 
eta!, 1995; Verge cl a/, 1995) . 
The physiologic role of th ese mediators singly and in co mbination 
is not currently completely understood; however, o ne may speculate 
that the production of one or more of these facto rs by Langerhans 
cells may ca use neurite ex tension towards those Langerhans cells, 
thereby accounting for the association seen histologically. 
W e used long-li ved ce il lin es de1ived from neonatal murine epidermal 
cells (Xu et al, 1995a,c). These cells were utili zed as surrogates for 
Langerhans cells to avo id co ntamination of popu lations ofLangerhans 
cells with other epidermal elements such as keratin ocytes, mebnocytes, 
and / or Merkel cells. Langerhans cells make up only 2% of the tota l 
epidermal pop ulation and it is difficu lt to obtain large numbers of 
highly purified Langerhans cells. H omogeneo us p opu lations of cells 
are parti cularly impo rtant for utili zation o f RT-PCR as even small 
numbers of contaminating cells could provide confounding results. 
XS52 cells have been widely used as surroga tes for Lmgerhans ce lls 
(Ariizumi et a/, 1995; Yokota et a/, 1996). They have many of th e 
characteristics of Langerhans ce lls in cluding th e abi li ty to present 
antigen (Xu eta/, 1995a,b,c; Tabshima cl a/, 1995) . T he ex pression 
of neurotrophi c t tctors and neuropeptide receptors by XS52 ce Ll s was 
compared with that ofLangerhans cells enri ched to 90% and enriched 
Langerhans ce ll s showed quite similar expression patterns to those of 
XS52-4D cells. Although contaminating keratinocytes are present in. 
this population, the nea rly identical results seen w ith the clo nal cell 
line suggest strongly that these results apply to Lan gerhans cells. 
Our observation tl1at expression ofNGF and bFGF differed amongs t 
clon es o f the XS52 parent line coupl ed wi.th the observa tion that so me 
of these clo nes are more efficient at anti gen presentati o n th an o th ers 
(Xu et al, l995c), suggests that expressio n of these fuctors may vary 
depending on th e activa tion state of the Langerhans cells. The maturity 
of Langerhans cells fo r antigen presentation is known to be regulated 
by several cytokines (Enk cl a/, 1993; Larsen cl a/, 1994) and , thus, 
th ese cytokin es may also regulate expressio n of neuro trophic fucto rs and, 
perhaps, neuropeptide receptors on Langerhans cell s. The regu lation of 
Langerhans celJs phys io logy by cyto kines is of particular interest 
beca use, depending on th eir activation state, keratinocytes can make 
many of these regulatory facto rs includin g G M-CSF, IL-1 0, and 
TNF-a, amongs t o thers (Enk and Katz, 1992; Gallo ct a/, 1992; Kolde 
ef a/, 1992). Furthermo re, upon trafficking to drai11in.g lymph nodes, 
Langerhans cells enter an environment where many cytokines n1ay be 
produced by resident lymphocytes . Neuron-derived factors may also 
play a role in Langerhans ceLls physiology within lymph nodes as the 
secondary lymphoid organs are known to be innervated (Giron cl a/, 
1980; Walk er and Codd, 1985). 
As a w hole, th ese data furth er support the idea that Langerhans cells 
function is regulated by neuropeptides and, furth er, suggests that 
Langerhans cells may be able to influence nerves through production 
of neurotrophic £:1c tors. 
This work t/las supported by N II--1 gm11t AR42429 (ROC), n C0 11tri/111tivll jin111 the 
Edith C. Bl11m E-'ouudatio11 rwd tftc A lbert t\11. Kligtt t<W Rcsc<urlt Fcllotllsl<ip <if. 
Deml!ltology Fott11datio11 (1--JT). 
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